Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Applied Therapeutics Inc (NASDAQ: APLT) closed at $0.35 in the last session, down -3.01% from day before closing price of $0.37. In other words, the price has decreased by -$3.01 from its previous closing price. On the day, 1.09 million shares were traded.
Ratios:
We take a closer look at APLT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.00 and its Current Ratio is at 3.00. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 185.63 while its Price-to-Book (P/B) ratio in mrq is 1.37.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -9.97%, while the 200-Day Moving Average is calculated to be -88.45%.
Shares Statistics:
A total of 141.58M shares are outstanding, with a floating share count of 117.55M. Insiders hold about 16.97% of the company’s shares, while institutions hold 74.93% stake in the company.
Earnings Estimates
A comprehensive evaluation of Applied Therapeutics Inc (APLT) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.09 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.46 and -$0.71 for the fiscal current year, implying an average EPS of -$0.57. EPS for the following year is -$0.41, with 3.0 analysts recommending between -$0.25 and -$0.71.
Revenue Estimates
Based on 4 analysts’ estimates, the company’s revenue will be $29.02M in the next fiscal year. The high estimate is $54.3M and the low estimate is $10.4M.
